Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess rheumatologic tolerability of letrozole in
postmenopausal patients with hormone receptor positive breast cancer having discontinued
anastrozole adjuvant treatment due to musculoskeletal disorders.